Wells Fargo
AKCA

Wells Fargo’s Akcea Therapeutics Inc AKCA Stock Holding History

Wells Fargo’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-447,981
Closed -$8.13M – 7430
2020
Q3 		$8.13M Buy
447,981
+386,038
+623% +$5.48M ﹤0.01% 2053
2020
Q2 		$849K Buy
61,943
+26,705
+76% +$412K ﹤0.01% 3942
2020
Q1 		$504K Sell
35,238
-13,836
-28% -$227K ﹤0.01% 4030
2019
Q4 		$830K Buy
49,074
+23,504
+92% +$437K ﹤0.01% 3989
2019
Q3 		$393K Sell
25,570
-14,013
-35% -$299K ﹤0.01% 4539
2019
Q2 		$929K Buy
39,583
+4,789
+14% +$118K ﹤0.01% 3918
2019
Q1 		$986K Buy
34,794
+21,518
+162% +$627K ﹤0.01% 3889
2018
Q4 		$400K Sell
13,276
-13,628
-51% -$382K ﹤0.01% 4475
2018
Q3 		$942K Sell
26,904
-7,148
-21% -$216K ﹤0.01% 4015
2018
Q2 		$807K Buy
34,052
+10,187
+43% +$243K ﹤0.01% 4134
2018
Q1 		$611K Sell
23,865
-8,531
-26% -$184K ﹤0.01% 4252
2017
Q4 		$563K Buy
32,396
+24,389
+305% +$478K ﹤0.01% 4310
2017
Q3 		$222K Buy
+8,007
New +$148K ﹤0.01% 4871

Wells Fargo's AKCA Position: Q4 2020 in Review

Wells Fargo sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 447,981 shares — an estimated $8.13M sold.

Wells Fargo first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $8.13M in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Wells Fargo reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Wells Fargo sold 447,981 Akcea Therapeutics Inc shares in Q4 2020, an estimated $8.13M.
  • Wells Fargo first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
  • Wells Fargo's Akcea Therapeutics Inc position peaked at $8.13M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Wells Fargo's 13F filing for Q4 2020, filed 9 Feb 2021.